tacrolimus and Lipodystrophy

tacrolimus has been researched along with Lipodystrophy* in 4 studies

Other Studies

4 other study(ies) available for tacrolimus and Lipodystrophy

ArticleYear
Acquired localized lipoatrophy in children is frequently caused by preceding injections: a retrospective study of 12 patients.
    International journal of dermatology, 2020, Volume: 59, Issue:5

    Topics: Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Infant; Injection Site Reaction; Injections, Intramuscular; Injections, Subcutaneous; Lipodystrophy; Male; Retrospective Studies; Subcutaneous Fat; Tacrolimus; Transplantation, Autologous; Treatment Outcome

2020
Case of lipodystrophia centrifugalis abdominalis infantilis successfully treated with topical application of tacrolimus.
    The Journal of dermatology, 2017, Volume: 44, Issue:4

    Topics: Abdomen; Administration, Topical; Child, Preschool; Humans; Immunosuppressive Agents; Lipodystrophy; Male; Tacrolimus

2017
Lipodystrophia centrifugalis abdominalis infantilis in a Caucasian girl: report of a case with perieccrine inflammation.
    Journal of cutaneous pathology, 2008, Volume: 35, Issue:10

    Lipodystrophia centrifugalis abdominalis infantilis (LCAI) is a rare, self-limiting disease typically affecting Asian children around the age of three. In classic cases, patients present with a hypopigmented patch with central atrophy and an erythematous border in the groin area. We present a case of LCAI affecting a female Caucasian toddler that shows striking perieccrine inflammation, a finding not previously reported in this entity. LCAI has been rarely reported in Caucasian children; as a result, there is sparse literature on the histopathological findings in this subset. This case illustrates how significant deep dermal and perieccrine inflammation can be seen in this condition, thus broadening the histopathological spectrum of this disorder.

    Topics: Child, Preschool; Dermatologic Agents; Eccrine Glands; Female; Groin; Humans; Immunohistochemistry; Inflammation; Lipodystrophy; Skin; Tacrolimus; White People

2008
Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy.
    Nature medicine, 2005, Volume: 11, Issue:7

    We describe the generation and characterization of the first inducible 'fatless' model system, the FAT-ATTAC mouse (fat apoptosis through targeted activation of caspase 8). This transgenic mouse develops identically to wild-type littermates. Apoptosis of adipocytes can be induced at any developmental stage by administration of a FK1012 analog leading to the dimerization of a membrane-bound, adipocyte-specific caspase 8-FKBP fusion protein. Within 2 weeks of dimerizer administration, FAT-ATTAC mice show near-knockout levels of circulating adipokines and markedly reduced levels of adipose tissue. FAT-ATTAC mice are glucose intolerant, have diminished basal and endotoxin-stimulated systemic inflammation, are less responsive to glucose-stimulated insulin secretion and show increased food intake independent of the effects of leptin. Most importantly, we show that functional adipocytes can be recovered upon cessation of treatment, allowing the study of adipogenesis in vivo, as well as a detailed examination of the importance of the adipocyte in the regulation of multiple physiological functions and pathological states.

    Topics: Adipocytes; Adipose Tissue; Animals; Apoptosis; Caspase 8; Caspases; Dimerization; Eating; Enzyme Activation; Glucose Intolerance; Inflammation; Insulin; Insulin Secretion; Leptin; Lipodystrophy; Lipopolysaccharides; Mice; Mice, Transgenic; Recombinant Fusion Proteins; Tacrolimus; Tacrolimus Binding Proteins

2005